A salt of morpholine cinnamide compound

PK139930AUndetermined Publication Date: 2009-01-17EISAI R&D MANAGEMENT CO LTD
0 Cites 0 Cited by

Patent Information

Application Number
PK200800661
Authority / Receiving Office
PK · PK
Patent Type
Applications
Current Assignee / Owner
Publication Date
2009-01-17
Patent Text Reader

Abstract

The present invention relates to a compound represented by the formula (I) or a pharmacologically acceptable salt thereof wherein R1 , R2 , R3 , and R4 are the same or different and each represent a hydrogen atom or a Cl-6 alkyl group; X1 represents a C1-6 alkylene group that may be substituted; Xa represents a methoxy group or a fluorine atom; Xb represents an oxygen atom or a methylene group, provided that Cb is only an oxygen atom when Xa is a methoxy group; and Ar1 represents an aryl group, pyridinyl group, aryloxy group, or pyridinyloxy group thast may have a substituent such as a halogen atom; and to use of the compound or salt as a pharmaceutical agent.
Need to check novelty before this filing date? Find Prior Art